| Morphine Milligram Equivalents (MME) Interagency Meeting |
Committee, Work group, Advisory group, or Task Force |
FDA, CDC, IHS |
NIDA |
Trans-agency workgroup to identify gaps in calculating daily morphine milligram equivalents (MMEs). |
| MOU among USDA/FDA/NIH |
Other |
FDA |
OD/OER |
Agreement for reciprocal cooperation to assist each agency in meeting its responsibilities in promoting proper laboratory animal care and welfare |
| Move Your Way Steering Committee |
Committee, Work group, Advisory group, or Task Force |
OASH |
NIA |
This committee assists in the planning and review of activities to disseminate and educate the public about the National Physical Activity Guidelines. |
| Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group |
Committee, Work group, Advisory group, or Task Force |
FDA |
NCI, NHLBI, NIA, NIAMS, NIBIB, NIDCD, NIDCR, NINDS |
The Multi-Agency Tissue Engineering Sciences (MATES) is an ad hoc interagency working group that provides a platform where federal agencies can interact efficiently and effectively to exchange information on tissue engineering and regenerative medicine. MATES members coordinate efforts related to cell therapy, gene therapy, biomaterials, tissue engineering, regenerative medicine and organ on a chip from research and development to commercialization. MATES holds monthly meetings to exchange information. |
| Multiagency Data Initiatives to Build Data Capacity for Patient-Centered Outcomes Research for COVID-19 |
Resource Development |
ASPE, AHRQ |
NCATS, NIDDK |
NIH is working with the HHS Office of the Assistant Secretary for Preparedness and Evaluation on several initiatives related to building data capacity for patient-centered outcomes research for COVID-19. The “Understanding COVID-19 Trajectory and Outcomes in the Context of MCC Through e-Care Plan Development” project (a collaboration between AHRQ, NIDDK, and ASPE) works to expand standards-based e-Care plan tools to facilitate aggregation and sharing of person-centered-planning data, including health concerns, social determinants of health, complex constellations of COVID 19 sequelae, and behavioral health concerns, across disparate systems for people living with multiple chronic conditions, their caregivers, and their care teams. The “National COVID-19 Longitudinal Research Database Linked to CMS Data” project (a collaboration between ASPE, NIDDK, and NCATS) works to evaluate disparities by looking at community characteristics using geocoding approaches and information on air quality and housing. It also seeks to capture care and outcomes of vulnerable populations such as patients on dialysis, nursing home residents, and low-income individuals. |
| Multiple Chronic Conditions eCare Plan Project |
Resource Development |
AHRQ, ASPE |
NIDDK |
The goal of this initiative is to build data capacity for conducting pragmatic, patient-centered outcomes research (PCOR) by developing an interoperable electronic care (eCare) plan to facilitate aggregation and sharing of critical patient-centered data across home, community, clinic and research-based settings by extracting data from point-of-care health systems and allowing transfer of that data cross settings. This is a joint initiative between the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Assistant Secretary for Planning and Evaluation (ASPE). |
| Muscular Dystrophy Coordinating Committee (MDCC) |
Committee, Work group, Advisory group, or Task Force |
ACL, CDC, FDA, HRSA |
NHLBI, NIAMS, NICHD, NINDS |
This Federal Advisory Committee coordinates activities relevant to the various forms of muscular dystrophy across the National Institutes of Health (NIH) and other federal agencies. The committee also includes members from patient organizations. Strategic planning efforts by the coordinating committee led to the development of an Action Plan for the Muscular Dystrophies, which contains specific research objectives appropriate to the missions of all committee member agencies and organizations, and thus serves as a central focus for research coordination. The plan is available at the MDCC web site. https://www.mdcc.nih.gov/ |
| MyHealthfinder Steering Committee |
Committee, Work group, Advisory group, or Task Force |
OASH, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA |
NCI, NIA, NLM |
The MyHealthfinder Steering Committee, comprised of federal partners from across HHS, provides insight into how MyHealthfinder (an online prevention and wellness resource from the HHS Office of Disease Prevention and Health Promotion) can be more useful to public health professionals and the clients they serve. The MyHealthfinder Steering Committee was formed in December 2020 and meets quarterly. |
| N3C Privacy-Preserving Record Linkage |
Resource Development |
ASPE, CMS |
NCATS |
Privacy-preserving record linkage (PPRL) significantly expands the scope of secure patient-level data for N3C and unlocks exciting new opportunities for clinicians, rearchers, and patients to better understand COVID-19. Users sign A Linkage Honest Broker Agreement (LHBA) and use de-identified tokens to get information from N3C. PPRL protects patient privacy, enhances accuracy, and enables diverse insights. |
| Nanotechnology Characterization Laboratory |
Resource Development |
FDA |
NCI |
Collaboration Type: Also Research Initiative The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The NCL serves as a national resource and knowledge base for cancer researchers and facilitates the development and translation of nanoscale particles and devices for clinical applications. |